-
Type
All -
Tags
Industrial -
Strategic pillar
All -
Beamlines
All -
From Year
All -
To Year
All -
Quarter
2024 - Q4- All
- 2025 - Q4
- 2025 - Q3
- 2025 - Q2
- 2025 - Q1
- 2024 - Q4
- 2024 - Q3
- 2024 - Q2
- 2024 - Q1
- 2023 - Q4
- 2023 - Q3
- 2023 - Q2
- 2023 - Q1
- 2022 - Q4
- 2022 - Q3
- 2022 - Q2
- 2022 - Q1
- 2021 - Q4
- 2021 - Q3
- 2021 - Q2
- 2021 - Q1
- 2020 - Q4
- 2020 - Q3
- 2020 - Q2
- 2020 - Q1
- 2019 - Q4
- 2019 - Q3
- 2019 - Q2
- 2019 - Q1
- 2018 - Q4
- 2018 - Q3
- 2018 - Q2
- 2018 - Q1
- 2017 - Q4
- 2017 - Q3
- 2017 - Q2
- 2017 - Q1
- 2016 - Q4
- 2016 - Q3
- 2016 - Q2
- 2016 - Q1
- 2015 - Q4
- 2015 - Q3
- 2015 - Q2
- 2015 - Q1
- 2014 - Q4
- 2014 - Q3
- 2014 - Q2
- 2014 - Q1
- 2013 - Q4
- 2013 - Q3
- 2013 - Q2
- 2013 - Q1
- 2012 - Q4
- 2012 - Q3
- 2012 - Q2
- 2012 - Q1
- 2011 - Q4
- 2011 - Q3
- 2011 - Q2
- 2011 - Q1
- 2010 - Q4
- 2010 - Q3
- 2010 - Q2
- 2010 - Q1
- 2009 - Q4
- 2009 - Q3
- 2009 - Q2
- 2009 - Q1
- 2008 - Q4
- 2008 - Q3
- 2008 - Q2
- 2008 - Q1
- 2007 - Q4
- 2007 - Q3
- 2007 - Q2
- 2007 - Q1
- 2006 - Q4
- 2006 - Q3
- 2006 - Q2
- 2006 - Q1
- 2005 - Q4
- 2005 - Q3
- 2005 - Q2
- 2005 - Q1
- 2004 - Q4
- 2004 - Q3
- 2004 - Q2
- 2004 - Q1
- 2003 - Q4
- 2003 - Q3
- 2003 - Q2
- 2003 - Q1
Publication | Beamlines | Type | Strategic Pillar |
---|---|---|---|
Cyr, Patrick; Fader, Lee D.; Burch, Jason D.; Pike, Kelly A.; Sietsema, Daniel V. et al. (2024). Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided Hybridization. ACS Medicinal Chemistry Letters 15(12) , 2201-2209. 10.1021/acsmedchemlett.4c00471. [PDB: 9mdc] | CMCF-ID | Peer-Reviewed Article | Health |
Poullennec, Karine G.; Jnoff, Eric; Abendroth, Jan; Bhuma, Naresh; Calmiano, Mark et al. (2024). Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies. Journal of Medicinal Chemistry 67(23) , 20879-20910. 10.1021/acs.jmedchem.4c01237. [PDB: 8uoj] | CMCF-ID | Peer-Reviewed Article | Health |
Vu, Binh T.; Dominique, Romyr; Fahr, Bruce J.; Li, Hongju H.; Fry, David C. et al. (2024). Discovery of Rezatapopt (PC14586), a First-in-Class, Small-Molecule Reactivator of p53 Y220C Mutant in Development. ACS Medicinal Chemistry Letters . 10.1021/acsmedchemlett.4c00379. [PDB: 9br4] | CMCF-ID | Peer-Reviewed Article | Health |
Abendroth, J.; Lorimer, D.D.; Vu, B.; Takana, N. (2024). Crystal structure of p53 Y220C mutant in complex with PC-9859. Protein Data Bank: 9br4. | CMCF-ID | PDB Deposition | Health |